Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Bristol-Myers Squibb Co. (NYSE:BMY)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Reports
Recent Events
Aug  1Dividend payment of $0.275
Location
345 Park Avenue
New York, NY 10154
Phone: (212) 546-4000
Fax: (212) 546-4020
Employees (last reported count): 44,000
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Subsidiaries
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 1%
·Over the last 6 months:
 · 3 insider sells; 261.0K shares
  (1.3% of insider shares)
·Institutional: 61% (61% of float)
(2,772 institutions)
·Net Inst. Selling: 6.79M shares (+0.58%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Bristol-Myers Squibb Company is a major producer and distributor of medicines. The Company's products include PRAVACHOL, GLUCOPHAGE, TAXOL, PLAVIX, BUSPAR, PARAPLATIN, ZERIT, MONOPRIL, CEFZIL, AVAPRO, SERZONE, CAPOTEN/CAPOZIDE, EXCEDRIN, VIDEX, infant formulas, ostomy products, and wound care products. On September 28, 2000, the Company announced the planned divestiture of its Clairol and Zimmer businesses. The Company announced on February 22, 2001 its intention to separate the Zimmer business in a tax-free spin-off to shareholders. The transaction was completed in August, 2001.
More from Market Guide: Expanded Business Description

Financial Summary
Bristol-Myers Squibb Company, through its divisions and subsidiaries, is a producer and distributor of consumer medicines, pharmaceuticals, nutritionals, medical devices and beauty care products. For the six months ended 6/30/01, net sales rose 6% to $9.40 billion. Net income from continuing operations rose 10% to $2.35 billion. Results reflect increases in both volume and selling prices of pharmaceutical products, and reduced expenditures for advertising and promotion.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Charles Heimbold, Jr., 67
Chairman
$3.5M
Peter Dolan, 45
Pres, CEO, Director
6.7M
Frederick Schiff, 53
CFO, Sr. VP
--  
Peter Ringrose, Ph.D., 54
CSO and Pres, Bristol-Myers Squibb Pharmacuetical Research Institute
--  
John McGoldrick, 60
Exec. VP and Gen. Counsel and Pres, Medical Devices Group
1.2M
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:BMYAs of 31-Aug-2001
Price and Volume
52-Week Low
on 6-Sep-2000
$49.938
Recent Price$56.14 
52-Week High
on 29-Dec-2000
$74.875
Beta0.47 
Daily Volume (3-month avg)4.41M
Daily Volume (10-day avg)3.64M
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+5.4%
52-Week Change
relative to S&P500
+41.4%
Share-Related Items
Market Capitalization$108.7B
Shares Outstanding1.94B
Float1.92B
Dividends & Splits
Annual Dividend (indicated)$1.10 
Dividend Yield1.96%
Last Split: 2 for 1 on 1-Mar-1999
Per-Share Data
Book Value (mrq)$4.92 
Earnings (ttm)$2.18 
Earnings (mrq)$0.56 
Sales (ttm)$9.47 
Cash (mrq)$1.62 
Valuation Ratios
Price/Book (mrq)11.40 
Price/Earnings (ttm)25.80 
Price/Sales (ttm)5.93 
Income Statements
Sales (ttm)$18.7B
EBITDA (ttm)$6.51B
Income available to common (ttm)$4.31B
Profitability
Profit Margin (ttm)23.0%
Operating Margin (ttm)30.8%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)24.75%
Return on Equity (ttm)46.58%
Financial Strength
Current Ratio (mrq)1.81 
Debt/Equity (mrq)0.15 
Total Cash (mrq)$3.15B
Short Interest
As of 8-Aug-2001
Shares Short13.3M
Percent of Float0.7%
Shares Short
(Prior Month)
11.8M
Short Ratio2.83 
Daily Volume4.70M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.